Ingevity Corp(NGVT)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Ingevity Corp (NGVT) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NGVT at 53.1/100 on a 32-signal composite quality model, placing it at rank #1,409 of 2,961 stocks — the top half of the AI-ranked universe. NGVT scores in the top quartile across earnings quality (92.4). Areas of concern include revenue growth (20.4) and institutional flow (20.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 45.1/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Ingevity Corp reports quarterly revenue of $314.1M, net income of $35.3M, free cash flow of $-24.1M. Top institutional holders of NGVT by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. NGVT trades on the NYSE exchange and files with the SEC under CIK 1653477. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NGVT daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Ingevity Corp directly from SEC EDGAR.